Hetero Healthcare Ltd., one of the most prominent Indian pharmaceutical companies, in collaboration with Enzene Biosciences Ltd., has announced the introduction of Perzea, their cheapest biosimilar of Pertuzumab.
Biocon Biologics Ltd. (BBL), a world leader in biosimilars and part of Biocon Ltd., announced today an important achievement with the inclusion of Yesafili biosimilar on the Ontario Drug Benefit (ODB) Formulary/Comparative Drug Index...
Noida-based Jubilant Pharma Limited has shared the news that its wholly-owned subsidiary, Jubilant Pharma Limited, has wrapped up a Post-marketing Adverse Drug Experience
Novo Nordisk revealed the findings of the REACH real-world study, which showed that Ozempic (once-weekly injectable semaglutide) was linked to a 23% lower risk of major adverse cardiovascular events like a heart attack or stroke when compared to
The National Institutes of Health (NIH) launched an initiative to advance research on whole person health that aims to create the first integrated knowledge network of healthy physiological function. This initiative takes a health approach...
Eli Lilly is preparing to introduce Orforglipron, its experimental oral weight-loss drug, in India, after the successful launch of its injectable therapy Mounjaro (tirzepatide) earlier this year. According to company executives
Biocon Biologics Ltd, a fully integrated global biosimilars company and a unit of Biocon Ltd, has obtained the US Food and Drug Administration (FDA) approval for their denosumab biosimilars
Since its injectable medication Stelara, which generated over $10 billion in sales last year, is up against fierce competition from less expensive competitors, J&J has been developing more practical psoriasis treatment choices
India's pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook
Elsevier has revealed a comprehensive AI platform for researchers to reshape how academic and corporate sectors conduct work. The goal of this advanced platform is to empower scientists to transition quickly from insights to real-world...